| Old Articles: <Older 12741-12750 Newer> |
|---|
 |
The Motley Fool
March 1, 2006
Bill Mann |
Tysabri: As Bad as AIDS? A report on the Elan/Biogen drug gets blown out of proportion on the eve of an FDA review. To say that a lot rides on the outcome of this meeting for Elan shareholders is an understatement.   |
The Motley Fool
March 1, 2006
Rich Duprey |
WebMD's New Lease on Life The online health company succeeds while its parent's vital signs sag. Investors, take note. |
The Motley Fool
March 1, 2006
Andy Cross |
Mine Safety's Rock-Solid 2005: Fool by Numbers Mine Safety released full-year 2005 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool
March 1, 2006
Rich Duprey |
Celebrex Doubles Lawsuit Risk A new study says the Pfizer painkiller doubles the risk of a heart attack. Investors, beware. |
The Motley Fool
March 1, 2006
Andy Cross |
Mine Safety's Bright Q4: Fool by Numbers Mine Safety released fourth-quarter 2005 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool
February 28, 2006
Tim Beyers |
Murdoch Goes Mobile News Corp. plans to spin off a new business for mobile content. For investors, that means it's time to start thinking about how the flood of mobile content will create both threats and opportunities. |
The Motley Fool
February 28, 2006
Stephen D. Simpson |
The New Doral Begins to Emerge The storm isn't over, but the worst should be past. Without current numbers, though, it's just too hard to say whether Doral is undervalued. |
The Motley Fool
February 28, 2006
Seth Jayson |
Ceradyne Ascendant The ceramics specialist is benefiting from an armor boom, but it's doing more than that. Ceradyne's stock may not look cheap, but it's likely a long way from seeing the top of the hill. Investors, take note. |
The Motley Fool
February 28, 2006
Tim Beyers |
Microsoft's Magnificent Vista? The newest Windows will come in a rainbow of customer-centric flavors. Investors need to be concerned that Vista's marketing pitch isn't more hope than reality. |
The Motley Fool
February 28, 2006
Tim Beyers |
Newmont Tarnished Gold failed to glitter for this mining firm. If you really must get into gold, there are many well-diversified gold funds that would add safety through diversification for investors. Considering Newmont's results, that safety seems to be worth paying for. |
| <Older 12741-12750 Newer> Return to current articles. |
